25 June 2020>: Clinical Research
Serum Amyloid A: A Potential Biomarker Assessing Disease Activity in Systemic Lupus Erythematosus
Cai-Mei Wang EFG , Jin-Huan Deng EFG , Guo-Fei Mao B , Yong-Ling He B , Xiang Shi AC*DOI: 10.12659/MSM.923290
Med Sci Monit 2020; 26:e923290
Table 3 The potential factors associated with active systemic lupus erythematosus (SLE) evaluated by binary logistic regression analysis.
Variables | OR | 95% CI | P-value |
---|---|---|---|
WBC (10/L) | 1.006 | 0.651–1.555 | 0.980 |
RDW (%) | 1.396 | 0.956–2.032 | 0.082 |
ESR (mm/h) | 1.051 | 1.003–1.102 | 0.037 |
Hs-CRP (mg/L) | 1.689 | 1.062–2.688 | 0.027 |
SAA (mg/L) | 1.772 | 1.101–2.851 | 0.01 |
OR – odds ratio; CI – confidence interval; WBC – white blood cell; RDW – red blood cell distribution width; ESR – erythrocyte sedimentation rate; Hs-CRP – hypersensitive C-reactive protein; SAA – serum amyloid A. |